GlassScriptPhysician profile
Michael C Giovingo
NPI 1962668624
$22,065.05
in general payments reported to CMS, 2019-2025
17 companies · $1,891 in 2025
The $1,891 reported for 2025 was more than what 79% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,811 · 2020: $2,854 · 2021: $5,407 · 2022: $6,196 · 2023: $2,289 · 2024: $1,617 · 2025: $1,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,197 · Honoraria: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,197.16 |
| Honoraria | $2,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iridex Corporation | $16,791.05 | 2019-2025 | |
| New World Medical,INC. | $1,322.13 | 2019-2025 | Ahmed Glaucoma Valve, Streamline, Clearpath |
| Glaukos Corporation | $1,232.14 | 2019-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr, Idose |
| Alcon Vision LLC | $924.07 | 2019-2024 | Hydrus Microstent, Clareon |
| Sight Sciences, INC. | $808.83 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $170.38 | 2019-2020 | |
| Amgen INC. | $169.45 | 2025 | Tepezza |
| Abbvie INC. | $149.99 | 2025 | |
| Allergan, INC. | $105.70 | 2019-2020 | |
| Nova Eye, INC. | $94.79 | 2024 | |
| Genentech, INC. | $87.66 | 2023 | Vabysmo |
| Bausch & Lomb Americas INC. | $75.46 | 2022-2023 | Miebo, Vyzulta |
| Ivantis, INC | $43.18 | 2021 | |
| Novartis Pharmaceuticals Corporation | $28.37 | 2019 | |
| Aerie Pharmaceuticals, INC. | $24.56 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $20.90 | 2025 | Tecnis Simplicity |
| Ocular Therapeutix, INC. | $16.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Giovingo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.